Most sunscreens promise to protect you from future damage. A few ambitious ones promise to repair existing damage. The ISDIN Eryfotona Ageless promises to do both of those things while also stimulating collagen production and blocking visible light — and then it has the audacity to look good doing it. It sounds like the kind of marketing overclaim that would make a dermatologist roll their eyes, except that this particular sunscreen has an actual clinical trial published in the Journal of Drugs in Dermatology that tested this exact formulation and found that 81% of participants showed improvement in photoaging signs after twelve weeks.
The Eryfotona Ageless is the cosmetically sophisticated sibling of ISDIN's Eryfotona Actinica, which has spent over fifteen years building a clinical evidence base around DNA Repairsomes technology. Both share the same core: zinc oxide as the sole mineral UV filter, and liposome-encapsulated photolyase enzymes derived from cyanobacteria that directly repair UV-induced DNA damage when activated by visible light. Where the Actinica is clinical and invisible, the Ageless adds a universal tint, anti-aging peptides, and a finish designed for people who want their sunscreen to double as skincare.
The formulation layers protection in a way that reveals ISDIN's pharmaceutical heritage. Zinc oxide at 10.7% provides broad-spectrum UVA and UVB absorption. Iron oxides deliver the tint while also blocking high-energy visible light — a detail that sounds like marketing but is genuinely important for anyone with melasma or hyperpigmentation, since HEV light is a documented trigger that zinc oxide alone doesn't fully address. DNA Repairsomes tackle the UV-induced structural DNA damage that accumulates over time. Ascorbic acid and ascorbyl palmitate provide free radical defense in both aqueous and lipid phases. And then there are the peptides.
Palmitoyl Tripeptide-38, marketed as Matrixyl Synthe'6, is a signal peptide that mimics matrikines — fragments of extracellular matrix proteins — to stimulate collagen synthesis. Pentapeptide-34 Trifluoroacetate upregulates the enzyme that produces Coenzyme Q10, boosting the skin's endogenous antioxidant capacity. These aren't throwaway ingredients listed at the tail end of the formula for marketing purposes — they're the reason this product exists as a separate SKU from the Actinica.
The texture is where ISDIN's formulation team earns their reputation. This is a mineral sunscreen — zinc oxide, the ingredient most associated with thick white paste — that feels like a tinted serum. The liquid emulsion flows out of the tube, spreads across the face with no resistance, and absorbs in seconds. The universal tint is sheer enough to blend into most light-to-medium skin tones, evening out redness and discoloration while providing a natural, luminous finish. It's not foundation. It won't cover a blemish. But for most people on most days, it provides enough coverage to skip the additional base makeup step entirely.
The shade universality has limits. Very fair skin with cool undertones may find the tint reads slightly warm or dark initially, though it does blend. Deeper skin tones beyond medium may find the coverage too sheer to meaningfully contribute to their shade match. A single universal shade is inherently a compromise, and while ISDIN threads the needle better than most, it can't serve everyone equally.
Performance over a wear day is strong. The matte-to-satin finish holds up for hours without becoming greasy or breaking down. Water resistance is rated at forty minutes, adequate for incidental sweating but not for beach days. The formula plays well under makeup for those who want additional coverage, creating a smooth, slightly tacky base that foundation adheres to without sliding.
The fragrance and denatured alcohol bear the same criticism as the Actinica. For a product developed by a pharmaceutical company, sold through dermatologist offices, and positioned for photodamaged skin, the inclusion of synthetic fragrance is a puzzling choice. The scent is mild and dissipates quickly, but its presence narrows the suitability window. The denatured alcohol contributes to the ultralight, fast-absorbing texture but may cause mild dryness on already-compromised skin.
At seventy dollars for one hundred milliliters, the Ageless is priced at a premium but not an unreasonable one for what it delivers. The peptide technology, DNA repair enzymes, and iron oxide visible light protection add genuine ingredient cost beyond a basic zinc oxide formula. A fifty-milliliter travel size at around forty-five dollars provides a lower entry point. HSA and FSA eligibility helps offset the cost for those with qualifying health spending accounts.
The twelve-week clinical trial by Kern et al. is what elevates this product from 'promising ingredients' to 'demonstrated results.' Most sunscreens are marketed on the basis of their ingredients' general evidence — zinc oxide protects, peptides stimulate collagen, antioxidants fight free radicals. Few have been tested as complete formulations in a controlled study. The finding that 63% of participants improved at six weeks and 81% at twelve weeks provides product-specific evidence that's rare in the sunscreen category.
This is a sunscreen for people who want their daily UV protection to work harder. The DNA repair, the anti-aging peptides, the visible light protection, and the elegant tinted finish combine to create something more than the sum of its ingredients. It isn't flawless — the fragrance shouldn't be there, the single shade doesn't serve everyone, and the price asks a lot. But for the photodamage-conscious consumer who wants the most from their morning sunscreen step, the Eryfotona Ageless makes a case that few competitors can match.
